Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Morange

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
La Revue De Medecine Interne|May 24, 2003
[Heterozygous prothrombin gene mutation G20210A and associated diseases]B Granel, P-E Morange, J Serratrice, et al.
Thrombosis and Haemostasis|March 11, 1998
Protein S deficiency: different biological phenotypes according to the assays usedD Brunet, M C Barthet, P E Morange, et al.
Diabetes|April 2, 1999
Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissueP E Morange, J Aubert, F Peiretti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 5, 2017
Peripartum bleeding management in a patient with CalDAG-GEFI deficiencyM Canault, P Saultier, S Fauré, et al.
British Journal of Haematology|December 21, 2004
Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohortP E Morange, D A Tregouet, C Frere, et al.
Circulation|March 17, 2004
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) studyP E Morange, C Simon, M C Alessi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 7, 2006
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene studyP E Morange, C Bickel, V Nicaud, et al.
European Journal of Human Genetics : EJHG|September 16, 2004
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME StudyP E Morange, L Tiret, N Saut, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 15, 2006
[Beneficial effect of a loading dose of 600 mg of clopidogrel on platelet parameters in patients admitted for acute coronary syndrome]T Cuisset, C Frère, J Quilici, et al.
Journal of Thrombosis and Haemostasis : JTH|April 17, 2014
Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction modelW Cohen, C Castelli, P Suchon, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
La Revue De Medecine Interne|May 24, 2003
[Heterozygous prothrombin gene mutation G20210A and associated diseases]B Granel, P-E Morange, J Serratrice, et al.
Thrombosis and Haemostasis|March 11, 1998
Protein S deficiency: different biological phenotypes according to the assays usedD Brunet, M C Barthet, P E Morange, et al.
Diabetes|April 2, 1999
Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissueP E Morange, J Aubert, F Peiretti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 5, 2017
Peripartum bleeding management in a patient with CalDAG-GEFI deficiencyM Canault, P Saultier, S Fauré, et al.
British Journal of Haematology|December 21, 2004
Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohortP E Morange, D A Tregouet, C Frere, et al.
Circulation|March 17, 2004
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) studyP E Morange, C Simon, M C Alessi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 7, 2006
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene studyP E Morange, C Bickel, V Nicaud, et al.
European Journal of Human Genetics : EJHG|September 16, 2004
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME StudyP E Morange, L Tiret, N Saut, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 15, 2006
[Beneficial effect of a loading dose of 600 mg of clopidogrel on platelet parameters in patients admitted for acute coronary syndrome]T Cuisset, C Frère, J Quilici, et al.
Journal of Thrombosis and Haemostasis : JTH|April 17, 2014
Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction modelW Cohen, C Castelli, P Suchon, et al.
Pageof 8